Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Microsoft Stock Hit My Target. Now I’m Stepping Back (NASDAQ:MSFT)

18 September 2026

PLS Group: Ngungaju Restart Adds Growth, But Lithium Prices Still Drive The Stock (OTCMKTS:PILBF)

18 September 2026

Nasdaq: I Am Buying (Together With Another One) (NASDAQ:NDAQ)

18 September 2026

Invesco Core Plus Bond Fund Q2 2026 Commentary (ACPSX)

18 September 2026

Xenon Pharmaceuticals Inc. (XENE) Discusses Azetukalner NDA Submission for Focal Seizures and Psychiatry Program Update Transcript

18 September 2026
Facebook X (Twitter) Instagram
Business Friday, Sep 18
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » Nasdaq: I Am Buying (Together With Another One) (NASDAQ:NDAQ)
News

Nasdaq: I Am Buying (Together With Another One) (NASDAQ:NDAQ)

thebusinesstimes.co.ukBy thebusinesstimes.co.uk18 September 20260 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
Share
Facebook Twitter LinkedIn Pinterest Email

This article was written by

I’m a long-term investor focused on U.S. and European equities, with a dual emphasis on undervalued growth stocks and high-quality dividend growers. Through years of experience, I’ve learned that sustained profitability—evident in strong margins, stable and expanding free cash flow, and high returns on invested capital—is a more reliable driver of returns than valuation alone. I manage one of my portfolios publicly on eToro, where I qualified as a Popular Investor, allowing others to copy my real-time investment decisions. My background spans Economics, Classical Philology, Philosophy and Theology. This interdisciplinary foundation sharpens both my quantitative analysis and my ability to interpret market narratives through a broader, long-term lens. I started investing when I became a father. By managing wisely what I received and earn, I aim to ensure for me and my children that we don’t have so much that we don’t have to do anything, but that we have enough assets to be free to do what we want. The goal is not to free myself from work, but to make sure I can work in the place and in a way where I can fully express myself.I partner with iREIT®+HOYA Capital, where I share exclusive content and run a dividend growth portfolio with buy/sell alerts.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of CBOE, NDAQ either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Microsoft Stock Hit My Target. Now I’m Stepping Back (NASDAQ:MSFT)

PLS Group: Ngungaju Restart Adds Growth, But Lithium Prices Still Drive The Stock (OTCMKTS:PILBF)

Invesco Core Plus Bond Fund Q2 2026 Commentary (ACPSX)

Xenon Pharmaceuticals Inc. (XENE) Discusses Azetukalner NDA Submission for Focal Seizures and Psychiatry Program Update Transcript

Envista Holdings Corporation (NVST) Analyst/Investor Day Transcript

BioVie Inc. (BIVI) Discusses Topline Phase 2 ADDRESS-LC Trial Data and the Potential of Bezisterim in Long Covid – Slideshow (NASDAQ:BIVI) 2026-09-17

The Future Is Too Uncertain For Duluth Holdings To Warrant An Upgrade (NASDAQ:DLTH)

Unum Continues To Deliberately Improve Its Business Mix (NYSE:UNM)

September’s 5 Dividend Growth Stocks With Yields Up To 7.03%

Editors Picks

PLS Group: Ngungaju Restart Adds Growth, But Lithium Prices Still Drive The Stock (OTCMKTS:PILBF)

18 September 2026

Nasdaq: I Am Buying (Together With Another One) (NASDAQ:NDAQ)

18 September 2026

Invesco Core Plus Bond Fund Q2 2026 Commentary (ACPSX)

18 September 2026

Xenon Pharmaceuticals Inc. (XENE) Discusses Azetukalner NDA Submission for Focal Seizures and Psychiatry Program Update Transcript

18 September 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

Envista Holdings Corporation (NVST) Analyst/Investor Day Transcript

18 September 2026

BioVie Inc. (BIVI) Discusses Topline Phase 2 ADDRESS-LC Trial Data and the Potential of Bezisterim in Long Covid – Slideshow (NASDAQ:BIVI) 2026-09-17

18 September 2026

The Future Is Too Uncertain For Duluth Holdings To Warrant An Upgrade (NASDAQ:DLTH)

17 September 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.